Noble Capital Markets Initiates Equity Research Coverage on Resources Connection (RGP)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Resources Connection today with his report titled "Poised to Capitalize on a New Paradigm"
Noble Capital Markets Initiates Equity Research Coverage on SKYX Platforms (SKYX)
Noble’s Equity Research Analyst Patrick McCann launched coverage on SKYX Platforms today with his report titled "Initiating Coverage: Introducing Smart Electrical Technology"
Noble Capital Markets Initiates Equity Research Coverage on NN Inc. (NNBR)
Noble’s Equity Research Analyst Joe Gomes launched coverage on NN Inc. today with his report titled "A Leading Manufacturer of High-Precision Metal Products"
Noble Capital Markets Initiates Equity Research Coverage on Conduent Inc. (CDNT)
Noble’s Equity Research Analyst Patrick McCann launched coverage on Conduent Inc. today with his report titled "Peering Through The Fog Of Its Transition"
Noble Capital Markets Initiates Equity Research Coverage on SelectQuote (SLQT)
Noble’s Equity Research Analyst Patrick McCann launched coverage on SelectQuote today with his report titled “Can It Cut Loose Its Heavy Debt Anchor?"
Noble Capital Markets Initiates Equity Research Coverage on Unicycive Therapeutics (UNCY)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Unicycive Therapeutics today with his report titled “Initiating Coverage With An Outperform Rating"
Noble Capital Markets Initiates Equity Research Coverage on ZyVersa Therapeutics (ZVSA)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on ZyVersa Therapeutics today with his report titled “Novel Therapies For Renal Diseases and Inflammation"
Noble Capital Markets Initiates Equity Research Coverage on Cadrenal Therapeutics (CVKD)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Cadrenal Therapeutics today with his report titled "Addressing Unmet Anticoagulation Needs In Orphan Populations"
Noble Capital Markets Initiates Research Coverage on AdTheorent (ADTH)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on AdTheorent today with his report titled "Positioned To Outshine Favorable Industry Growth"
Noble Capital Markets Initiates Equity Research Coverage on Xcel Brands (XELB)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on Xcel Brands today with his report titled “Likely To Be The Trough Toward Improved Results"
Noble Capital Markets Initiates Equity Research Coverage on Eledon Pharmaceuticals (ELDN)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Eledon Pharmaceuticals today with his report titled "Initiating Coverage With An Outperform Rating and $10 Price Target"
Noble Capital Markets Initiates Equity Research Coverage on QuantaSing Group Limited (QSG)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on QuantaSing Group today with his report titled "A Favorable Course For Revenue and Cash Flow Growth"
